On March 20, 2026, Picard Medical, Inc. announced its participation in the American College of Cardiology's Annual Scientific Session & Expo, scheduled for March 28 to March 30, 2026, in New Orleans, Louisiana. The company will present a poster featuring early preclinical data on its next-generation Emperor Total Artificial Heart technology. This innovative platform aims to provide a fully implantable, autoregulating solution for patients with advanced heart failure, building on the success of the SynCardia Total Artificial Heart, which is the first artificial heart approved by both the U.S. FDA and Health Canada. The presentation will be led by Duffy Elmer, Engineering Project Manager at SynCardia LLC, who emphasized the importance of this development in expanding treatment options and improving the quality of life for patients. The conference will also provide an opportunity for attendees to engage with SynCardia's engineering and clinical teams to learn more about the current clinical technology and future directions of the Emperor program. This participation is expected to enhance the company's visibility in the medical community and potentially lead to increased interest from investors and healthcare professionals.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.